Payne D J, Marriott M S, Amyes S G
Department of Bacteriology, Medical School, University of Edinburgh, UK.
J Antimicrob Chemother. 1989 Aug;24(2):103-10. doi: 10.1093/jac/24.2.103.
Spontaneous ceftazidime resistant mutants were obtained from an Escherichia coli K12 J62-2 expressing the TEM-1 beta-lactamase (mutation frequency = 10(-9). These mutants produced beta-lactamases with similar molecular weights, kinetic parameters and isoelectric points (pI) to the beta-lactamases produced by ceftazidime resistant clinical isolates which have recently been identified in this laboratory. Mutant enzyme A focused as a doublet band at pI 5.3 with an additional weak pI 5.4 band. The doublet co-focused with the TEM-E2 beta-lactamase, produced by a ceftazidime resistant Klebsiella oxytoca isolate, which was originally obtained in a Liverpool hospital. Mutant enzyme B had a pI identical to the TEM-E1 beta-lactamase produced by a ceftazidime resistant clinical isolate of E. coli found in Belgium. These results suggest that the two beta-lactamases in the clinical strains may have come from simple mutations of the TEM-1 beta-lactamase gene.
从一株表达TEM-1β-内酰胺酶的大肠杆菌K12 J62-2中获得了自发的头孢他啶抗性突变体(突变频率 = 10^(-9))。这些突变体产生的β-内酰胺酶与本实验室最近鉴定的头孢他啶抗性临床分离株产生的β-内酰胺酶具有相似的分子量、动力学参数和等电点(pI)。突变酶A在pI 5.3处聚焦为双峰带,还有一条较弱的pI 5.4带。该双峰与由一株头孢他啶抗性产酸克雷伯菌分离株产生的TEM-E2β-内酰胺酶共聚焦,该分离株最初是在利物浦一家医院获得的。突变酶B的pI与在比利时发现的一株头孢他啶抗性大肠杆菌临床分离株产生的TEM-E1β-内酰胺酶相同。这些结果表明,临床菌株中的两种β-内酰胺酶可能来自TEM-1β-内酰胺酶基因的简单突变。